Live
RecursionA Look At Recursion Pharmaceuticals (RXRX) Valuation After Recent Clinical And Cost Management Updates - simplywall.st10x Genomics BlogWhy 10x Genomics (TXG) stock is down today - MSN10x Genomics NewsA Look At 10x Genomics (TXG) Valuation After Recent Share Price Moves - simplywall.st10x Genomics NewsA Look At 10x Genomics (TXG) Valuation After Recent Share Price Moves - simplywall.stMerck & Co.Merck & Co. Inc. stock (US58933Y1055): Earnings beat and pipeline update drive investor interest - AD HOC NEWSMettler ToledoMettler Toledo (MTD) Margin Slippage Tests Bullish Earnings Growth Narratives - simplywall.stLabCorpLabcorp stock (US50540R4092): Diagnostic and drug development leader in focus for US investors - AD HOC NEWSCellFerroptosis inhibition enhances liver and lung graft functionCell<em>Streptomyces</em> enrichment in roots during drought is uncoupled from plant benefit and is driven by host suppression of iron uptake and immunityCellAI-predicted spatial transcriptomics unlocks breast cancer biomarkers from pathologyCellMultimodal clocks of human agingCellThe rise of polyploids during environmental upheaval
10x Genomics Blog Mar 25, 2026

10x Genomics Inc (TXG) Trading 4.54% Higher on Mar 25 - GuruFocus

10x Genomics Inc (TXG) Trading 4.54% Higher on Mar 25 - GuruFocus

Original
Body unavailable. Use the original source.